Highlander Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $27.9K | Sell |
153
-74
| -33% | -$12.8K | 0.01% | 491 |
|
|
2023
Q4 | $35.2K | Hold |
227
| – | – | 0.01% | 447 |
|
|
2023
Q3 | $34K | Hold |
227
| – | – | 0.01% | 424 |
|
|
2023
Q2 | $31K | Hold |
227
| – | – | 0.01% | 376 |
|
|
2023
Q1 | $36K | Hold |
227
| – | – | 0.02% | 350 |
|
|
2022
Q4 | $37K | Sell |
227
-50
| -18% | -$7.67K | 0.02% | 332 |
|
|
2022
Q3 | $37K | Hold |
277
| – | – | 0.02% | 317 |
|
|
2022
Q2 | $42K | Sell |
277
-825
| -75% | -$126K | 0.02% | 310 |
|
|
2022
Q1 | $179K | Sell |
1,102
-650
| -37% | -$94.4K | 0.08% | 159 |
|
|
2021
Q4 | $237K | Hold |
1,752
| – | – | 0.11% | 134 |
|
|
2021
Q3 | $189K | Sell |
1,752
-300
| -15% | -$34.3K | 0.1% | 146 |
|
|
2021
Q2 | $231K | Hold |
2,052
| – | – | 0.12% | 130 |
|
|
2021
Q1 | $222K | Buy |
2,052
+1,550
| +309% | +$166K | 0.12% | 123 |
|
|
2020
Q4 | $54K | Hold |
502
| – | – | 0.03% | 271 |
|
|
2020
Q3 | $44K | Buy |
502
+300
| +149% | +$28.2K | 0.03% | 301 |
|
|
2020
Q2 | $20K | Buy |
+202
| New | +$17.8K | 0.01% | 402 |
|
|
2019
Q2 | – | Sell |
-500
| Closed | -$40K | – | 680 |
|
|
2019
Q1 | $40K | Sell |
500
-500
| -50% | -$40.9K | 0.02% | 352 |
|
|
2018
Q4 | $89K | Hold |
1,000
| – | – | 0.06% | 236 |
|
|
2018
Q3 | $95K | Hold |
1,000
| – | – | 0.05% | 265 |
|
|
2018
Q2 | $93K | Hold |
1,000
| – | – | 0.05% | 265 |
|
|
2018
Q1 | $97K | Buy |
1,000
+500
| +100% | +$54.9K | 0.06% | 261 |
|
|
2017
Q4 | $48K | Hold |
500
| – | – | 0.04% | 362 |
|
|
2017
Q3 | $44K | Sell |
500
-300
| -38% | -$22.8K | 0.03% | 371 |
|
|
2017
Q2 | $58K | Hold |
800
| – | – | 0.05% | 317 |
|
|
2017
Q1 | $52K | Sell |
800
-600
| -43% | -$37.7K | 0.04% | 329 |
|
|
2016
Q4 | $88K | Hold |
1,400
| – | – | 0.08% | 258 |
|
|
2016
Q3 | $88K | Hold |
1,400
| – | – | 0.08% | 254 |
|
|
2016
Q2 | $87K | Hold |
1,400
| – | – | 0.08% | 261 |
|
|
2016
Q1 | $80K | Sell |
1,400
-700
| -33% | -$39K | 0.07% | 274 |
|
|
2015
Q4 | $124K | Sell |
2,100
-3,400
| -62% | -$196K | 0.12% | 209 |
|
|
2015
Q3 | $299K | Buy |
5,500
+1,800
| +49% | +$117K | 0.28% | 99 |
|
|
2015
Q2 | $249K | Hold |
3,700
| – | – | 0.22% | 115 |
|
|
2015
Q1 | $217K | Buy |
3,700
+1,700
| +85% | +$103K | 0.19% | 132 |
|
|
2014
Q4 | $131K | Buy |
+2,000
| New | +$126K | 0.11% | 208 |
|
Other funds holding ABBV
Highlander Capital Management's ABBV Position: Q1 2024 in Review
Highlander Capital Management reduced its AbbVie (ABBV) stake by 33% in Q1 2024, selling an estimated $12.8K and leaving 153 shares worth $27.9K. The position accounts for 0.01% of the portfolio, ranked #491.
Highlander Capital Management first reported a position in ABBV in Q4 2014 and has held it in 34 quarters since. The position peaked at $299K in Q3 2015. 3,380 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.
- Highlander Capital Management held 153 shares of AbbVie worth $27.9K as of Q1 2024.
- Highlander Capital Management sold 74 AbbVie shares in Q1 2024, an estimated $12.8K.
- AbbVie made up 0.01% of Highlander Capital Management's portfolio in Q1 2024, its #491 holding.
- Highlander Capital Management first reported a position in AbbVie in Q4 2014 and has held it in 34 quarters since.
- Highlander Capital Management's AbbVie position peaked at $299K in Q3 2015.
- 3,380 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.
Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.